Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Ionetix Corp / DE / in our court records and SEC 8-K records (as of 2026-10-18).
- Leadership changes: the latest reported is Michael Tarnok, Director (Form 8-K filed 2026-05-20). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Eli Lilly & Co (filed 2026-07-24).
Who is behind it
Ionetix Corp / DE /: incorporated in Delaware; business address in Lansing, Michigan; industry In Vitro & In Vivo Diagnostic Substances (S-1, 2026-08-07).
Officers and directors, each with the role and the filing that names them:
- Kevin Cameron: Executive Officer (Form D, 2026-04-23)
- Phieu Phun: Executive Officer (Form D, 2026-04-23)
- Gregory Martin: Director (Form D, 2026-04-23)
- Douglas Boothe: Director (Form D, 2026-04-23)
- Michael Stewart: Executive Officer, Director (Form D, 2026-04-23)
- David Landskowsky: Director (Form D, 2026-04-23)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-07-24 | Eli Lilly & Co | 7.9% |
| Schedule 13G, 2026-04-20 | Ospraie Real Assets Fund LP | 19.9% |
| Schedule 13D, 2026-04-20 | Shamrock Ionetix LLC | 7.2% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-05-20 | Michael Tarnok | Director | appointed | 2026-05-18 |
| Form 8-K, 2026-05-20 | Kevin Cameron | Director | appointed |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2026-04-23 | $32.33M | $32.33M |
Latest IPO step: Ionetix Corp / DE / filed to go public (S-1, 2026-08-07).
IPO filings: S-1, 2026-08-07.
Acquisitions reported on Form 8-K, Item 2.01: completed an acquisition (2026-04-16).
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/ionetix-corp-de